Fibroblastic reticular cells (FRCs) create T-cell-supportive niches within lung cancer tumors, facilitating T-cell migration, clustering, and activation. This study highlights FRCs’ potential as therapeutic targets to boost anti-tumor immunity in non-small cell lung cancer (NSCLC).